Lunai Bioworks (LNAI) Debt to Equity (2011 - 2022)

Lunai Bioworks' Debt to Equity history runs 8 years deep, the most recent figure standing at $0.07 for Q3 2022.

• In Q3 2022, Debt to Equity rose 137.35% year-over-year to $0.07; the TTM figure through Sep 2022 stood at $0.07 (up 137.35% YoY), while the FY2022 annual figure was $0.06, up 140.42% from the prior year.
• Debt to Equity was $0.07 for Q3 2022 at Lunai Bioworks, up from $0.06 in the prior quarter.
• In the past five years, Debt to Equity ranged from a high of $0.16 in Q1 2019 to a low of $0.03 in Q4 2019.
• Historically, Debt to Equity has averaged $0.07 across 5 years, with a median of $0.05 in 2021.
• The sharpest annual moves came in 2019 and 2022: Debt to Equity tumbled 83.41% in 2019, then surged 140.42% in 2022.
• A 5-year view of Debt to Equity shows it stood at $0.15 in 2018, then tumbled by 83.41% to $0.03 in 2019, then surged by 66.55% to $0.04 in 2020, then sank by 33.61% to $0.03 in 2021, then soared by 137.35% to $0.07 in 2022.
• The last three Debt to Equity figures came in at $0.07 (Q3 2022), $0.06 (Q2 2022), and $0.03 (Q3 2021), per Business Quant data.